发明名称 Therapeutic Uses of Elsiglutide
摘要 The invention relates to therapeutic uses of elsiglutide, particularly for protecting and stimulating bone marrow and peripheral blood cell type activity or immune-response in patients compromised due to the administration of chemotherapeutic agents. The invention further provides uses of elsiglutide to enhance the antitumor activity of cytotoxic chemotherapeutic agents and target specific biological agents.
申请公布号 US2017087216(A1) 申请公布日期 2017.03.30
申请号 US201615266907 申请日期 2016.09.15
申请人 Helsinn Healthcare SA 发明人 Pietra Claudio;Lovati Emanuela;Rustum Youcef M.
分类号 A61K38/26;A61K31/4745;A61K45/06 主分类号 A61K38/26
代理机构 代理人
主权项 1. A method of increasing bone marrow activity in a subject suffering myelosuppression as a consequence of cytotoxic therapy comprising administering to said subject an elsiglutide regimen before, during or after administering a cycle of said cytotoxic therapy to said subject.
地址 Lugano CH